150 likes | 408 Views
Endometrial Cancer. District 1 ACOG Medical Student Teaching Module 2009. Symptoms. Post menopausal bleeding Endometrial cells on Pap Perimenopausal with irregular heavy menses, increasingly heavy menses Premenopausal with abnormal uterine bleeding with history of anovulation.
E N D
Endometrial Cancer District 1 ACOG Medical Student Teaching Module 2009
Symptoms • Post menopausal bleeding • Endometrial cells on Pap • Perimenopausal with irregular heavy menses, increasingly heavy menses • Premenopausal with abnormal uterine bleeding with history of anovulation
Differential Diagnosis for PMB • Exogenous estrogen use- ie tamoxifen • Atrophic endometritis/vaginitis • Endometrial/cervical polyps • Endometrial hyperplasia • Endometrial Cancer • Other gynecologic cancers
Risk factors for Endometrial Cancer • Increased estrogen • Hormone therapy • Obesity • Anovulation/PCOS • Estrogen secreting tumors • Older age • Infertility • Early menarche • Late menopause • Genetics • HNPCC • Caucasian
Preoperative Work-up • Endometrial biopsy • Ultrasound • For suspected advanced stage may need: • Cystoscopy • Sigmoidoscopy • Pelvic and Abdominal CT • Labs • CBC • Chem 7 • Liver function tests • EKG, CXR
Endometrial Hyperplasia (EIN) • Precursor to endometrial cancer • Risk of progression related to cytologic atypia • Presents with abnormal bleeding • Simple • Benign irregular dilated glands • No atypia: 1% progress • Atypia: 8% progress • Complex • Proliferation of glands with irregular outlines, back to back crowding of glands, but no atypia • No atypia: 3% progress • Atypia: 29% progress
Staging of Endometrial Cancer • I: Confined to uterine corpus • IA: limited to endometrium • IB: invades less than ½ of myometrium • IC: invades more than ½ of myometrium
Staging of Endometrial Cancer • II: invades cervix but not beyond uterus • IIA: endocervical gland involvement only • IIB: cervical stroma involvement
Staging of Endometrial Cancer • III: local and/or regional spread • IIIA: invades serosa/adnexa, or positive cytology • IIIB: vaginal metastasis • IIIC: metastasis to pelvic or para-aortic lymph nodes
Staging of Endometrial Cancer • IVA: invades bladder/bowel mucosa • IVB: distant metastasis
Five Year Survival • Stage I: 81-91% • 72% diagnosed at this stage • Stage II: 71-78% • Stage III: 52-60% • Stage IV: 14-17% • 3% diagnosed at this stage
Spread Patterns • Direct extension • most common • Transtubal • Lymphatic • Pelvic usually first, then para-aortic • Hematogenous • Lung most common • Liver, brain, bone
Treatment • Stage IB or less: total hyst/BSO/PPALND, cytology • Stage IC to IIB: total hyst/BSO/PPALND, cytology, adjuvant pelvic XRT • Stage III: total hyst/BSO/PPALND, cytology, adjuvant chemotherapy • Stage IV: palliative XRT and chemotherapy
Histologic Types • Estrogen dependent • Endometrioid- most common • Non estrogen dependent- worse prognosis • Papillary Serous • Clear cell • Adenosquamous • Undifferentiated
Other Types of Uterine Cancer • Leiomyosarcoma • Rapidly growing fibroid should be evaluated • Stromal sarcoma • Carcinosarcoma (MMMT) MMMT leiomyosarcoma